Clinical trial
Study of Weekly Clofarabine for the Treatment of Relapsed/Refractory Chronic…
NCT00081887 · M.D. Anderson Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00081887 |
|---|---|
| Title | Study of Weekly Clofarabine for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia |
| Official title | Phase I Study of Weekly Clofarabine for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | Genzyme, a Sanofi Company Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Chronic Lymphocytic Leukemia, Leukemia |
| Intervention type | Drug |
| Interventions | Clofarabine |
| Enrollment | 8 |
| Start date | May 1, 2004 |
| Primary completion | May 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Apr 27, 2004 |
| Last update posted | Aug 1, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: